People | May 03, 2026
Sanofi India appoints Rahul Bhatnagar as Chairman of Board of Directors
Rahul Bhatnagar succeeds Aditya Narayan, who completed a decade-long distinguished tenure
Rahul Bhatnagar succeeds Aditya Narayan, who completed a decade-long distinguished tenure
The microbiology unit generated $645 million in revenue in 2025 and sits within Thermo Fisher’s Specialty Diagnostics segment
The company posted revenue of Rs. 703 crore in Q4 FY26
Tamir brings more than 20 years of experience in the medical technology sector
Both join the leading CRDMO’s executive committee to drive global people strategy and commercial expansion
Pharma and biotech infrastructure firm targets 25–30% growth as Middle East and Africa emerge as key expansion markets
The Danish biotech company confirmed the global study will begin in the second half of 2026
Steady growth led by biologics and CRDMO business, EBITDA margin at 25% with continued investments in ADCs, peptides, and digital capabilities
The Puducherry facility, dedicated to Ibuprofen and its derivatives, is equipped with advanced infrastructure to serve both domestic and international markets
Subscribe To Our Newsletter & Stay Updated
